The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2022

Filed:

Mar. 06, 2018
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Panayiotis Stevis, Tarrytown, NY (US);

David Esopi, Tarrytown, NY (US);

Jesper Gromada, Tarrytown, NY (US);

Jorge Haller, Tarrytown, NY (US);

Yashu Liu, Tarrytown, NY (US);

Andrew Murphy, Tarrytown, NY (US);

William Olson, Tarrytown, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/32 (2006.01); C12Q 1/66 (2006.01); C12N 9/96 (2006.01); G01N 33/74 (2006.01); C12N 9/04 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/32 (2013.01); C12N 9/0006 (2013.01); C12N 9/96 (2013.01); C12Q 1/66 (2013.01); C12Y 101/01239 (2013.01); G01N 33/743 (2013.01); G01N 2500/02 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01);
Abstract

Screening methods as well as kits for identifying modulators of hydroxysteroid (17-beta) dehydrogenase (HSD17B) family member proteins, such as HSD17B13, are provided. The methods comprise screening molecules for their capacity to modulate the HSD17B family member protein, including inhibiting the HSD17B family member protein, as measured by substrate depletion, product concentration from the HSD17B family member protein substrate conversion or NADH concentration, levels of labeled substrate, luciferin light emission, or combinations thereof. Inhibitors of HSD17B family member proteins identified through the screening methods may be used to treat liver diseases, disorders, or conditions in which the HSD17B family member protein plays a role.


Find Patent Forward Citations

Loading…